AI Article Synopsis

  • There has been a significant increase in mucormycosis cases in India following the second wave of COVID-19, with over 40,000 cases reported.
  • The rise in mucormycosis contrasts with other countries where different fungal pathogens like Aspergillus and Candida are more common in COVID-19 patients.
  • The text discusses potential causes of this outbreak, suggesting that COVID-19 weakens the immune response while identifying other contributing factors, indicating a two-hit mechanism involving both viral infection and additional iatrogenic or environmental influences.

Article Abstract

There has been a surge of mucormycosis cases in India in the wake of the second wave of COVID-19 with more than 40000 cases reported. Mucormycosis in patients of COVID-19 in India is at variance to other countries where Aspergillus, Pneumocystis, and Candida have been reported to be the major secondary fungal pathogens. We discuss the probable causes of the mucormycosis epidemic in India. Whereas dysglycaemia and inappropriate steroid use have been widely suggested as tentative reasons, we explore other biological, iatrogenic, and environmental factors. The likelihood of a two-hit pathogenesis remains strong. We propose that COVID-19 itself provides the predisposition to invasive mucormycosis (first hit), through upregulation of GRP78 and downregulation of spleen tyrosine kinase involved in anti-fungal defense, as also through inhibition of CD8+ T-cell mediated immunity. The other iatrogenic and environmental factors may provide the second hit which may have resulted in the surge.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782544PMC
http://dx.doi.org/10.14336/AD.2021.0811DOI Listing

Publication Analysis

Top Keywords

iatrogenic environmental
8
environmental factors
8
mucormycosis
5
pathogenetic dilemma
4
dilemma post-covid-19
4
post-covid-19 mucormycosis
4
india
4
mucormycosis india
4
india surge
4
surge mucormycosis
4

Similar Publications

Comprehensive review of phthalate exposure: Health implications, biomarker detection and regulatory standards.

J Steroid Biochem Mol Biol

December 2024

Department of Applied Chemistry and Chemical Engineering, Islamic University, Kushtia 7003,  Bangladesh; Institute of Glass and Ceramic Research and Testing (IGCRT), Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka 1205, Bangladesh.

Phthalates are a wide family of chemicals that are used in many different industrial applications used in many different industrial applications, including the production of plastics, toys, food packaging particularly for kids, and medical equipment. Due to their various chemical and physical properties, phthalates may negatively impact humans, animals, and the environment. Thus the potential for phthalate exposure and harm to humans, animals, and the environment is high because its presence is alarming.

View Article and Find Full Text PDF

As rates of obesity rise worldwide, incidence of metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease, is increasing, worsening the burden of healthcare systems. The council of the Federation of International Societies for Pediatric Gastroenterology, Hepatology, and Nutrition (FISPGHAN) identified the topic of MASLD epidemiology, treatment, and prevention as a global priority issue to be addressed by an expert team, with the goal to describe feasible and evidence-based actions that may contribute to reducing MASLD risk. The FISPGHAN member societies nominated experts in the field.

View Article and Find Full Text PDF

An 86-year-old woman lost consciousness at home. Tracheal intubation was performed in the ambulance during transport to our hospital. Computed tomography (CT) showed right putaminal hemorrhage in her brain, right pneumothorax, and mediastinal emphysema.

View Article and Find Full Text PDF

When the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) was published in 2013, there was a firestorm of controversy about the elimination of the bereavement exclusion. Proponents of this change and of the proposed "complicated grief" designation believed that this change would help clinicians recognise major depression in the context of recent bereavement. Other researchers and clinicians have raised concerns about medicalising grief.

View Article and Find Full Text PDF

Background: Physician grief, as defined by Kenneth Doka as disenfranchised grief, refers to "the grief that individuals experience when they incur a loss that is not openly acknowledged, publicly mourned, or socially supported." The experience of patient deaths on the emotional health of young doctors is unknown. The after-effects like stress, anxiety, burnout, depression, and others indirectly have a potential impact on decision-making and patient care.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!